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It Is All in the Numbers 
STANTON A. GLANTZ, PHD, FACC, AJSOCI.~TE EDITOR, JACC 
The new edhors of rhe lorrrnnl ojrhe Am-!cm C&J~P of 
Cordiobgy have decided that one of the editor< should be 
responsible for ensuring the statistical accuracy of studies 
published in the Journal. We have implcmec,ed this quality 
control by ensuring that every monuscripr that is returned to 
an author for reviKions is first reviewed for itatistical issues. 
Although I have lot done a formal study of the kinds of 
problems appeariitg in the manuscripts, several recurring 
areas of difficult!< have emerged. About one third of the 
papers have no s!atistical problems when they are initially 
accepted. Occasi-Inally, a paper that would have been ac- 
ceptable for 0th :I reasons j; rejected ou purely statistical 
grounds. Most tl the time, the papers have some aethod- 
ologic difficulties that the authors are expected to fix to 
revising the manuscript; sometimes corrrcting the stat!stical 
methods actually leads to alterations in the paper‘s ccnclu- 
sions. 
The problems identified in manuscripts submitted Io 
JACC-inappropriate use of the I test, use of panmetric 
statistical tests when the underlying assumptions are badly 
violated, problems with the study design that introduce 
biases toward treatments and drawing negative conclusions 
on the basis of small sample sizes-are typical problems that 
have been identified in several reviews of the medical 
literature over the years (I). Each of these problems is 
briefly reviewed here, together with some guidelines on 
avoiding them. 
laappmpriate useofthc I test. The Student I test is the most 
commonly used statistical method in biomedical research. The 
unpaired f test is used appropriately 10 compare the mean 
responses of two treatments or twogroups of ditrent individ- 
uals, as in a comptison of mean blood pressure in men and 
women: the paired t test is used to compare mean responses in 
the same individuals before and after an intervention, as in a 
coraparison of blood pressures measured in the same patients 
before and after they received a drug. 
In addition to these appropriate uses, the I test is widely 
misapplied to compare treatments or responses when there 
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are three or more treatment conditions by compticg each 
pair of treatmeats two at a lime. For example, if one is 
comparing a placebo and two drugs it is common to use I 
tests 10 compare placebo with drug A. placebo with drug B, 
and drug A with dr!!g B. Because these comparisons are no1 
independent. rhis profedureviolates the assumptions under- 
lying the I test. If a statisticat comparison is considered to 
reveal a significant difference when p c 0.05 for each 
individual test. then in making the three comparisons just 
men?ioned the overall risk of erroneously concluding that 
one of the treatments had an effect is approximately 3 x 
0.05 = 15% l.because there is a 5% false positive error rafe in 
each of the individual tests). Thus. by using multiple t tests 
to compare more than two groups, the risk of a false positive 
conclusiot+that is. asserting that a treatment had an effect 
when in fact it did not-is higher than the nominal 5% risk 
used for rhe individual tests. Similar problems arise when 
comparing interventions over time with multiple t rests. 
The appropriate statistical method to use in this situation 
is nor the I test but analysis of variance, the multigroup 
generalization of the r test. There are two broad categories of 
analysis of variance. Factorial analysis of variance is the 
generalization ofthe unpaired I test. which involves compar- 
ing three or more treatment groups consisting of different 
iodividuals. Repeated measures analysis of variance is the 
generalization of the paired r test. which is used for analyz- 
ing data collected in the same individuals over multiple 
interventions. lfan analysis of variance, which examines nN 
of the data at once, detects a significant difference, it is then 
reasonable to use one of many multiple comparison pm+ 
dures to isolate which of the groups are different. 
Another situation in which people often misuse I test5 is 
to compare two relationships over time-say. the response 
over time of blood pressure after giving two different druss. 
It is common to compare the responses to the two drugs at 
each time period or the responses over time to each dmg by 
using multiple I tests. A more accurate and sensitive method 
would be to use a linear regression model to describe the 
temporal relationship and then compare ihe linear regres- 
sions obtained over time for the different conditions (21. It is 
possible to collapse the entire analysis into a sin& muWe 
regression aralysis using dummy variables (2) as well as IO 
acc~un: for repeated observations in the same individuals. 
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Use of nonparametric tests when the underlying assump 
lions are badly vkdsted. The 1 test aid analyris sf vatix~e 
are so-called parametric statistical techniques because the 
theory underlying these methods assumes that the popula- 
tions from which the data were drawn follow a normal 
(bell-shaped) curve and that the only differences associated 
iYith the different treatments is a change in the means of 
these populations, but not in the standard deviation param- 
eters. While the parametric methods are robust, the results 
will still be reasonably accurate even if there are moderate 
deviations from these assumptions. These methods produce 
unreliable results when there are serious deviations from the 
assl!mptions of normality and equal variance (that is, equal 
standard deviations). If the data appear not lo meet these 
assumptions it is more appropriate fo use nonpararnetrlc 
methods such as the Mann-Whitney rank sum test (instead of 
an unpaired I test), the Kruskal-Wallis analysis of variance 
on ranks (instead of parametric analysis of variance), rhe 
Wilcoxon signed rank lest (instead of the paired r test) or the 
Friedman one-way analysis of variance based on ranks 
(instead of repeated measures analysis of variance). Using 
these nonparametric methods when appropriate produces 
more reliable results than using paramet.ic methods. Some 
authors (3) believe that. because the nonparamelric methods 
are generally only slightly less sensitive than the parametric 
methods even when the data meet the assumptions of the 
parametric methods, nonparametric methods should be used 
most of the time. 
Drawing negative conclusions on the basis of small sample 
sizes. One of the primary goals of clinical research is to 
identify new treatments or diagnostic tests and fo clarify 
their safety and efficacy. Such studies are often expensive 
and difficult to conduct, especially when investigators are 
studying relatively rare conditions for which recruiting suit- 
able patients is a problem. During the last year several 
manuscripts submitted to JACC reported new therapies as 
“safe and effective” when the investigators found no failures 
or complications in the small number of patients studied. 
Although finding no failures in a small number of patients is 
encouraging, it does nol prove safc:y or efficacy. For exam- 
ple, if there are no failures in six patients, the actual failure 
rate could be as high as 50% (i.e., the 95% confidence 
interval for the true failure rate extends up to about 50%). 
With no failure in IO patients, the 95% confidence interval 
for the failure rate extends all the way to 30%. Because 
drawing negative conclusions based on small sample size is 
sometimes necessary, investigators (and readers) need to be 
aware of Ihe severe limitations in this procedure (4). In 
particular. for such a negative conclusion, it is imperative 
that the authors not only present the observed failure rate. 
but also compute the confidence intervals for the results, and 
discuss lhem in their report, 
A related issue is that of concluding that there is no 
dikence between two treatmenls or conditions. Although 
most investigators have focused on the false positive 
error rate in statistical tests (known as the type I, or II, 
error), they also need to be concerned about the false 
negative error, that is, the possibility of failing to conclude 
that a difference exists when there really is one. This 
latter form of error is known as the type 11, or p, error. 
The sensitivity of a test lo detect a specified difference, 
which equals I minus the probability of a type II error, is 
known as the power of the test. Many people have come to 
accept a 5% risk of a false positive result (i.e., p C 0.05) as 
an appropriate level for concluding there is a significant 
difference between Iwo treatments. Similarly, most people 
prefer that experiments yielding negative results have a 
power of at least 80% (i.e., an 88% chance of concluding 
that there is a significant difference between the Merent 
groups under study when one really exists). Computing the 
power of a test depends on the level of confidence you wish 
to have in drawing a positive wnclusion (the p value you 
consider statistically significant), the sample size and the 
size of the effect deemed north detecting. These factors 
often combine to make it difficult to reach the desired 80% 
power. 
in any even’, studies reaching negative conclusions 
should present lhe power to detect a clinically meaning- 
ful effect and discuss the power in the overall interpre- 
tation of the study. It is usually difficult lo pin down 
investigators as to what is “clinically meaningful,” but this 
is a crucial part of presenting the results of a study, partic- 
ularly if the results arc negative. (This is not IO say that 
MCC refuses to publish negative s!~d!es: such studies can 
often be as important as positive studies in terms of man- 
agement of patients or basic understanding of the cardiovas- 
cular system.) Because power calculations often reveal low 
power to back up negative conclusions, it is often necessary 
to enter more patients or other subjects into the study to 
support a negative conclusion with a reasonable level of 
confidence. 
Uncontrolled and nonrandomized studies. When evalnat- 
ing a new treatment, investigators often wish to report the 
results in terms of :he overatl success rate. However. it is 
important to have a reasonable control group to compare the 
results with. particularly because of the placebo effect in 
which the simple provision of treatment itself leads some 
people to feel better regardless of the actual eficacy of the 
treatment. These control subjects can be untreated persons 
or patients receiving a conventional therapy. It is welt 
established that presentation of results without an adequate 
control almost always overstates the value and efficacy of 
Ihe therapy under study. 
A related issue is the need 1o randomize patients into the 
various treatment groups. If treatments are not randomiy 
assigned. there are many opportunities for bias to be intro- 
duced into the study through the processes of patient selec- 
tion and treatment allocation. Although it is not always 
possible to randomize patients in a study, this issue needs to 
he carefully considered and discussed as a limitation when 
randomization is no1 possible. Other approaches, such as 
matching the audy group with patients of similar character- 
istics who did not receive the treatment in question. can be 
used to compensate for some of the limitations of nonran- 
domized studies. 
Conclusions. Although rhe kinds of smtistical errors dis- 
cussed here rarely lead to rejection of a paper that otherwise 
would have been accepted for publicatior. correcting these 
ditficulties can change the conclustons reached. Careful 
consideration of the statistical and methodologic aspects of 
research in its design. conduct and reporting will improve 
the quality of publications in the Jorrrnnl of rlrr Amwicon 
Cofkge ofCordiology and, if authors deal with these prob- 
lems before manuscripts are submitted. 
view and pubiication process. 
will speed the re- 
